180 related articles for article (PubMed ID: 11971654)
1. Mitochondrial NADH dehydrogenase from Plasmodium falciparum and Plasmodium berghei.
Krungkrai J; Kanchanarithisak R; Krungkrai SR; Rochanakij S
Exp Parasitol; 2002 Jan; 100(1):54-61. PubMed ID: 11971654
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dehydrogenases in the aerobic respiratory chain of the rodent malaria parasite Plasmodium yoelii yoelii.
Kawahara K; Mogi T; Tanaka TQ; Hata M; Miyoshi H; Kita K
J Biochem; 2009 Feb; 145(2):229-37. PubMed ID: 19060309
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial oxygen consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium falciparum.
Krungkrai J; Burat D; Kudan S; Krungkrai S; Prapunwattana P
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):636-42. PubMed ID: 10928353
[TBL] [Abstract][Full Text] [Related]
4. Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain.
Mi-Ichi F; Miyadera H; Kobayashi T; Takamiya S; Waki S; Iwata S; Shibata S; Kita K
Ann N Y Acad Sci; 2005 Nov; 1056():46-54. PubMed ID: 16387676
[TBL] [Abstract][Full Text] [Related]
5. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite.
Krungkrai J
Biochim Biophys Acta; 1995 Apr; 1243(3):351-60. PubMed ID: 7727509
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial ubiquinol-cytochrome c reductase and cytochrome c oxidase: chemotherapeutic targets in malarial parasites.
Krungkrai J; Krungkrai SR; Suraveratum N; Prapunwattana P
Biochem Mol Biol Int; 1997 Aug; 42(5):1007-14. PubMed ID: 9285069
[TBL] [Abstract][Full Text] [Related]
7. Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
Chavalitshewinkoon-Petmitr P; Worasing R; Wilairat P
Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):733-8. PubMed ID: 12041546
[TBL] [Abstract][Full Text] [Related]
8. Glucose-6-phosphate dehydrogenase from Plasmodium berghei: kinetic and electrophoretic characterization.
Buckwitz D; Jacobasch G; Kuckelkorn U; Megow D
Biomed Biochim Acta; 1990; 49(2-3):S295-300. PubMed ID: 2201291
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria.
Biagini GA; Viriyavejakul P; O'neill PM; Bray PG; Ward SA
Antimicrob Agents Chemother; 2006 May; 50(5):1841-51. PubMed ID: 16641458
[TBL] [Abstract][Full Text] [Related]
10. Malarial dihydroorotate dehydrogenase mediates superoxide radical production.
Krungkrai J
Biochem Int; 1991 Jul; 24(5):833-9. PubMed ID: 1663740
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
[TBL] [Abstract][Full Text] [Related]
12. A chimeric cysteine protease of Plasmodium berghei engineered to resemble the Plasmodium falciparum protease falcipain-2.
Singh A; Walker KJ; Sijwali PS; Lau AL; Rosenthal PJ
Protein Eng Des Sel; 2007 Apr; 20(4):171-7. PubMed ID: 17430972
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
14. Effect of salinomycin-Na on malaria parasites (Plasmodium falciparum and P. berghei).
Mehlhorn H; Ganster HJ; Raether W
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Mar; 256(3):305-13. PubMed ID: 6375210
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of Plasmodium falciparum succinate dehydrogenase.
Suraveratum N; Krungkrai SR; Leangaramgul P; Prapunwattana P; Krungkrai J
Mol Biochem Parasitol; 2000 Feb; 105(2):215-22. PubMed ID: 10693744
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria of mammalian Plasmodium spp.
Fry M; Beesley JE
Parasitology; 1991 Feb; 102 Pt 1():17-26. PubMed ID: 2038500
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium berghei: partial purification and characterization of the mitochondrial cytochrome c oxidase.
Krungkrai J; Krungkrai SR; Bhumiratana A
Exp Parasitol; 1993 Sep; 77(2):136-46. PubMed ID: 8397100
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterparts.
Akoachere M; Iozef R; Rahlfs S; Deponte M; Mannervik B; Creighton DJ; Schirmer H; Becker K
Biol Chem; 2005 Jan; 386(1):41-52. PubMed ID: 15843146
[TBL] [Abstract][Full Text] [Related]
19. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
Joet T; Eckstein-Ludwig U; Morin C; Krishna S
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
[TBL] [Abstract][Full Text] [Related]
20. The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenases.
McMillan PJ; Stimmler LM; Foth BJ; McFadden GI; Müller S
Mol Microbiol; 2005 Jan; 55(1):27-38. PubMed ID: 15612914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
